Straumann stock gains as Morgan Stanley lifts rating and shares trade near mid-range of 52-week band

Published on 09/11/2026 at 15:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Straumann stock traded around 94.78 Swiss francs on the SIX Swiss Exchange on September 11, 2026, about 1.3 percent above the opening level. Morgan Stanley upgraded Straumann stock to Equal Weight on September 11, 2026, after previously rating it Underweight.

Reinraum-Fertigung von Dentalimplantaten mit Ingenieuren an Präzisionsmaschinen — Straumann Holding AG (CH0012280076) betreibt moderne Reinraum-Fertigung für präzise Dentalimplantate in der Schweiz, Illustration mit AI erstellt.

Straumann Holding AG stock (ISIN CH0012280076) traded at 94.78 Swiss francs on the SIX Swiss Exchange at around 12:28 p.m. local time on September 11, 2026, representing a gain of 1.3 percent versus the opening price of 94.30 Swiss francs in that session and placing the shares among the stronger performers in the SPI index on the day.

Morgan Stanley shifts Straumann rating

As Newsquawk reported on September 11, 2026, Morgan Stanley upgraded Straumann stock to Equal Weight from its previous Underweight rating, signaling a more balanced view of the dental implant specialist within the broker's coverage universe.

In a parallel analyst summary published on September 11, 2026, MarketScreener highlighted that Morgan Stanley set a price target of 89 Swiss francs for Straumann, framing the stock as fairly valued around that level compared with its current trading price in the mid-90s.

Shares trade firmly on SIX

According to intraday data from finanzen.ch, Straumann shares were quoted at 94.78 Swiss francs in the SIX SX session at 12:28 p.m. on September 11, 2026, up 1.3 percent from the opening level of 94.30 Swiss francs and extending intraday gains to a high of 95.26 Swiss francs earlier in the day.

The same intraday overview shows that the stock’s current price of 94.78 Swiss francs sits 29.80 percent above the 52-week low and 15.90 percent below the 52-week high of 109.80 Swiss francs reached on July 1, 2026, placing Straumann stock roughly in the middle zone of its one-year trading corridor on September 11, 2026.

In a morning snapshot on September 11, 2026, finanzen.ch reported Straumann shares at 94.74 Swiss francs at 9:28 a.m. on SIX SX, a 1.2 percent advance compared with the opening mark, underlining that the positive tone in the stock persisted through the session.

Valuation, expectations and earnings outlook

In a performance review that uses the previous day's closing price as a reference, finanzen.ch calculated that an illustrative investment of 10,000 Swiss francs three years ago, when Straumann closed at 128.00 Swiss francs, would be worth 7,310.94 Swiss francs based on the closing price of 93.58 Swiss francs on September 10, 2026, corresponding to a decrease of 26.89 percent over that period.

The same analysis from finanzen.ch places Straumann’s market capitalization at 14.86 billion Swiss francs as of its latest update in September 2026, which, together with the current share price in the mid-90s Swiss francs, provides investors with a snapshot of the group’s size in the global dental implant and orthodontics market.

Analyst consensus figures cited by finanzen.ch indicate that experts currently expect Straumann to generate earnings per share of 3.23 Swiss francs in fiscal year 2026, which investors can use to gauge the implied price-to-earnings ratio relative to the present share price.

With the same source stating that Straumann shareholders received a dividend of 1.00 Swiss franc per share in fiscal year 2025 and that a dividend of 1.09 Swiss francs per share is anticipated for fiscal year 2026, the expected year-on-year increase of about 9 percent in the payout suggests that management aims to continue a pattern of gradual dividend growth, even though the exact dividend decision will ultimately depend on reported results and board approval.

Operational scale and sector positioning

In terms of its workforce, an overview page on TradingView notes that Straumann employed around 25,940 people as of September 10, 2026, underscoring the scale at which the Swiss-based medical devices group operates in the global dental and orthodontic solutions market.

In a related healthcare industry snapshot, Yahoo Finance lists Straumann as part of the broader medical devices industry, with a market capitalization reference of 18.194 billion in its comparative table, which highlights that Straumann ranks among the larger specialized dental device manufacturers within the European healthcare segment.

For investors, Straumann’s positioning as a focused provider of dental implants, orthodontic clear aligners and digital equipment means that its growth prospects depend not only on macroeconomic trends but also on continued innovation in treatment solutions and the expansion of dental care access in both established and emerging markets.

Risks and the balance of views

The price target of 89 Swiss francs set by Morgan Stanley, as reported by MarketScreener on September 11, 2026, sits below the current trading level around 94.78 Swiss francs, which implies that the broker sees limited upside from the present price and potentially a modest downside, a reminder that not all analysts view the recent share strength as sustainable in the near term.

The three-year performance analysis from finanzen.ch, showing a 26.89 percent decline in the value of a hypothetical Straumann investment over that horizon, underlines that despite Straumann’s strong market position, shareholders have faced periods of significant volatility and price pressure, reflecting factors such as changing growth expectations, valuation compression and broader equity market swings.

At the same time, the expectation of a 1.09 Swiss franc dividend per share for fiscal year 2026, up from 1.00 Swiss franc in 2025, and the projected earnings per share of 3.23 Swiss francs demonstrate that analysts still anticipate ongoing profitability and capacity for dividend growth, offering a counterweight to concerns about the share price’s long-term trajectory.

Straumann stock price snapshot

Straumann stock can be taken at a reference price of 94.78 Swiss francs on the SIX Swiss Exchange as of 12:28 p.m. local time on September 11, 2026, reflecting a 1.3 percent intraday gain against the opening level of 94.30 Swiss francs on that day and leaving the shares trading 15.90 percent below the 52-week high of 109.80 Swiss francs achieved on July 1, 2026 and 29.80 percent above the 52-week low in the same period.